ID
36487
Description
Pilot Study of Atorvastatin for Orthopedic Surgery Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02197065 Brief Summary: Up to 35% of hip fracture patients have been shown to experience heart injury after surgery, and as many as 10% have a heart attack or die in the three months after surgery. Hip and knee arthroplasty patients are also at risk of cardiovascular complications. Patients who have these complications have higher levels of inflammation postoperatively. Statins (such as atorvastatin/Lipitor) lower cholesterol and also lessen inflammation. Both of these effects are important in preventing heart attacks. Statins have been shown to reduce the risk of heart attacks in non-surgical patients, and to protect from heart attacks in patients having heart surgery. Whether statins can prevent heart attacks in orthopedic patients is not known. In this pilot study the investigators will treat 30 orthopedic surgery patients (hip fracture, hip or knee arthroplasty) with either atorvastatin or placebo (a capsule with no study drug). Patients will start the study drug prior to surgery and take it for 45 days after surgery. Neither the doctors nor the patients will know whether they are taking atorvastatin or placebo. The investigators will look for evidence of inflammation and heart injury after surgery. The investigators hypothesize that atorvastatin will lessen the degree of postoperative inflammation found in these patients. In this study, the investigators will use a very sensitive test of heart injury that can detect problems even when patients have no symptoms. The investigators hypothesize that this test will demonstrate silent heart injury in over 50% of the hip fracture patients and over 30% of arthroplasty patients in our study. The results of this trial will help us to develop a larger study in 1000 hip fracture and joint replacement patients to determine whether atorvastatin protects orthopedic surgery patients from heart injury and other complications of surgery.
Link
https://clinicaltrials.gov/show/NCT02197065
Keywords
Versions (1)
- 5/17/19 5/17/19 -
Copyright Holder
Hospital for Special Surgery, New York
Uploaded on
May 17, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Atorvastatin as Post-OP NCT02197065
Eligibility Criteria
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Pathological Hip fracture (cancer)
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0019557
- UMLS CUI [1,2]
- C0016663
- UMLS CUI [1,3]
- C0678226
- UMLS CUI [1,4]
- C0006826
Description
Recent Statin Use
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1524063
- UMLS CUI [1,2]
- C0360714
- UMLS CUI [1,3]
- C0332185
Description
Statin intolerance
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1744706
- UMLS CUI [1,2]
- C0360714
Description
Myocardial infarction or unstable angina
Data type
boolean
Alias
- UMLS CUI [1]
- C0155626
- UMLS CUI [2]
- C0002965
Description
Cardial Handicap
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0262926
- UMLS CUI [1,2]
- C0027051
- UMLS CUI [2,1]
- C0262926
- UMLS CUI [2,2]
- C0948089
- UMLS CUI [3,1]
- C0262926
- UMLS CUI [3,2]
- C0002962
- UMLS CUI [4,1]
- C0262926
- UMLS CUI [4,2]
- C0027056
Description
Hip fracture with peripheral artery disease
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0019557
- UMLS CUI [1,2]
- C1704436
Description
Hip fracture with cerebral insult
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0019557
- UMLS CUI [1,2]
- C0262926
- UMLS CUI [1,3]
- C0007787
- UMLS CUI [2,1]
- C0019557
- UMLS CUI [2,2]
- C0262926
- UMLS CUI [2,3]
- C0038454
Description
Muscle Disorder
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0026845
- UMLS CUI [1,2]
- C0012634
Description
Liver Disease
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0201899
- UMLS CUI [1,2]
- C0205404
- UMLS CUI [2,1]
- C0151905
- UMLS CUI [2,2]
- C0205250
Description
Renal disease
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0022658
- UMLS CUI [1,2]
- C0205404
- UMLS CUI [2]
- C0151577
Description
HIV Protease Inhibitor or Hepatitis C Protease Inhibitor
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0087111
- UMLS CUI [1,2]
- C0162714
- UMLS CUI [2,1]
- C0087111
- UMLS CUI [2,2]
- C0019196
- UMLS CUI [2,3]
- C0033607
Description
Antimicrobial therapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0014806
- UMLS CUI [2]
- C0055856
- UMLS CUI [3]
- C0027996
- UMLS CUI [4]
- C0360363
Description
Pregant or Breastfeeding
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
- UMLS CUI [3]
- C0032992
Similar models
Eligibility Criteria
- StudyEvent: Eligibility
C0392806 (UMLS CUI [2])
C0086511 (UMLS CUI [3])
C0016663 (UMLS CUI [1,2])
C0678226 (UMLS CUI [1,3])
C0006826 (UMLS CUI [1,4])
C0360714 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
C0360714 (UMLS CUI [1,2])
C0002965 (UMLS CUI [2])
C0027051 (UMLS CUI [1,2])
C0262926 (UMLS CUI [2,1])
C0948089 (UMLS CUI [2,2])
C0262926 (UMLS CUI [3,1])
C0002962 (UMLS CUI [3,2])
C0262926 (UMLS CUI [4,1])
C0027056 (UMLS CUI [4,2])
C1704436 (UMLS CUI [1,2])
C0262926 (UMLS CUI [1,2])
C0007787 (UMLS CUI [1,3])
C0019557 (UMLS CUI [2,1])
C0262926 (UMLS CUI [2,2])
C0038454 (UMLS CUI [2,3])
C0012634 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,2])
C0151905 (UMLS CUI [2,1])
C0205250 (UMLS CUI [2,2])
C0205404 (UMLS CUI [1,2])
C0151577 (UMLS CUI [2])
C0162714 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C0019196 (UMLS CUI [2,2])
C0033607 (UMLS CUI [2,3])
C0055856 (UMLS CUI [2])
C0027996 (UMLS CUI [3])
C0360363 (UMLS CUI [4])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])